Blog  ›  Selank vs Semax: Simple Research Dosing Comparison Guide

Selank vs Semax: Simple Research Dosing Comparison Guide

Jun 11, 2026 4 min Cognitive
TL;DR
Selank and Semax are synthetic peptides studied in neuroscience research. Selank leans toward anxiety-related research; Semax toward cognitive and neuroprotective research. Both have been examined in the same studies, making direct comparison possible — but neither has full clinical approval outside Russia.

Two Peptides, One Comparison

If you've been reading about research peptides, you've probably bumped into Selank and Semax in the same breath. They're both synthetic, both studied for brain-related effects, and both come from Russian neuroscience research. But they are not the same thing. Let's break it down simply.

What Is Selank?

Selank is a synthetic peptide made from a molecule called tuftsin — a natural compound your immune system already uses. Scientists added extra amino acids to make it more stable in the body. Research has focused on its calming, anxiety-reducing properties.[3]

One study found that Selank affects genes tied to the GABA system — the same brain system that anti-anxiety drugs like diazepam (Valium) target.[6] GABA is basically the brain's "slow down" signal. This helps explain why researchers are so interested in Selank for anxiety models.

What Is Semax?

Semax is built from a fragment of a hormone called ACTH. ACTH normally tells your adrenal glands to release stress hormones, but this particular fragment — positions 4 through 10 — doesn't do that. Instead, research suggests it supports brain-derived neurotrophic factor (BDNF), a protein that helps neurons survive and grow.[1]

Semax is more often studied for cognitive support, focus, and neuroprotection rather than anxiety relief. Think of it as the "sharpen things up" peptide in research settings, while Selank is more the "calm things down" peptide.

How Does Research Dosing Differ?

This is where many readers get confused. Research dosing for these peptides is often administered as nasal drops in studies, and the amounts used differ. Always check a reliable calculator when reading study protocols — unit conversions matter a lot here.

  • Selank research doses: Studies commonly use doses around 300 µg/kg in animal models.[6] Human-focused research has used intranasal delivery in the microgram range.
  • Semax research doses: Animal and early human studies also use intranasal delivery, with amounts typically in the low-to-mid microgram range per dose. Brain imaging research used single intranasal administrations.[2]
  • Both peptides inhibit enzymes that break down enkephalins — natural pain and mood regulators — suggesting overlapping biochemical pathways.[4]

Quick Comparison List

  • Origin: Selank → tuftsin analog | Semax → ACTH 4-10 analog
  • Primary research focus: Selank → anxiety, mood | Semax → cognition, neuroprotection
  • Main mechanism studied: Selank → GABAergic system[6] | Semax → BDNF pathways[1]
  • Delivery in studies: Both primarily intranasal
  • Shared finding: Both affect enzyme activity tied to mood regulation[4]
  • Brain imaging: Both alter amygdala connectivity, but in different ways[2]

What Does Brain Imaging Show?

A fascinating 2020 study scanned the brains of 52 healthy people after they received either Selank, Semax, or a placebo. Using resting-state fMRI — a scan that watches how brain regions talk to each other at rest — researchers found that both peptides changed how the amygdala (your brain's alarm center) connected to the temporal cortex. But the changes were different for each peptide.[2] This supports the idea that they work through related but distinct paths.

Parkinson's Research: A Shared Test Case

Both peptides have also been studied in rat models of Parkinson's disease. Researchers damaged dopamine neurons with a toxic compound and then gave the rats either Semax or Selank. Selank reduced anxiety-like behavior in those rats — the same calming effect seen in healthy animals. Semax did not show the same anxiety effect in that model.[3] This again highlights their different profiles.

How to Choose What to Read About

Here's a simple rule of thumb for navigating the research literature:

  • If you're curious about stress, anxiety, or mood research → start with Selank.
  • If you're curious about memory, focus, or neuroprotection research → start with Semax.
  • If you want to understand dosing units used in studies → use the calculator to convert between mcg/kg and flat microgram doses.

Both peptides are classed as neuroactive research compounds.[1] Neither is FDA-approved as a drug in the United States. This content is strictly for educational and research-reading purposes — always consult a qualified professional for any health decisions.

Sources

  1. Therapeutic Peptides in Orthopaedics: Applications, Challenges, and Future Directions. — Journal of the American Academy of Orthopaedic Surgeons. Global research & reviews, 2026. PMID 41490200.
  2. Functional Connectomic Approach to Studying Selank and Semax Effects. — Doklady biological sciences : proceedings of the Academy of Sciences of the USSR, Biological sciences sections, 2020. PMID 32342318.
  3. Peptides semax and selank affect the behavior of rats with 6-OHDA induced PD-like parkinsonism. — Doklady biological sciences : proceedings of the Academy of Sciences of the USSR, Biological sciences sections, 2017. PMID 28702721.
  4. [Semax and selank inhibit the enkephalin-degrading enzymes from human serum]]. — Bioorganicheskaia khimiia, 2001. PMID 11443939.
  5. Pharmacological Aspects of Neuro-Immune Interactions. — Current pharmaceutical design, 2018. PMID 28875850.
  6. Selank Administration Affects the Expression of Some Genes Involved in GABAergic Neurotransmission. — Frontiers in pharmacology, 2016. PMID 26924987.
See the dosage chart — Selank
An anxiolytic nootropic peptide derived from tuftsin.
Selank

FAQ

What is the main difference between Selank and Semax?
Selank is derived from a tuftsin analog and is primarily researched for anxiety-reducing effects linked to the GABA system. Semax comes from an ACTH hormone fragment and is more studied for cognitive and neuroprotective properties tied to BDNF. Think calming vs. sharpening in research contexts, though both affect overlapping brain pathways.[2]
Are Selank and Semax used the same way in studies?
Both peptides are commonly administered intranasally in research studies, including human brain imaging work. However, the exact doses and protocols differ. Animal studies often use weight-based dosing around 300 µg/kg, while human research uses smaller intranasal microgram amounts. Always check a dosing calculator when reading study protocols to avoid unit confusion.[6]
Do Selank and Semax share any mechanisms?
Yes. Both peptides inhibit enzymes that break down enkephalins — natural compounds involved in mood and pain signaling. This shared biochemical action suggests overlapping mechanisms despite their different primary research profiles. Both also alter amygdala brain connectivity, though in distinct ways as shown by fMRI research.[4][2]
Is either peptide approved as a medicine?
Semax and Selank have been used clinically in Russia, but neither holds FDA approval in the United States or broad regulatory approval in most Western countries. Research outside Russia remains largely preclinical — meaning most data comes from animal studies or small human trials. This site covers them strictly for educational, research-reading purposes.[1]
For research and educational use only. Not medical advice.